Philip Poortmans - Researcher Profile

Publications

4 shown

Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review

Fatma Ataman , Philip Poortmans , Roger Stupp +2 more

The phase III randomised European Organisation for Research and Treatment of Cancer (EORTC) and National Cancer Institute of Canada Clinical Trail Group (NCIC) Intergroup trial ...

2004 European Journal of Cancer 36 citations

Breast cancer

Nadia Harbeck , Frédérique Penault‐Llorca , Javier Cortés +6 more

2019 Nature Reviews Disease Primers 2678 citations

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Fátima Cardoso , S. Kyriakides , Shinji Ohno +5 more

2019 Annals of Oncology 2079 citations

Breast cancer

Sibylle Loibl , Philip Poortmans , Monica Morrow +2 more

2021 The Lancet 1433 citations

Frequent Co-Authors

Researcher Info

h-index: 4
Publications: 4
Citations: 6,226
Institution: Instituut Verbeeten

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7400-2293

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.